5,106 followers
New Research: Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China: Background: The pneumococcal vaccine has been considered as the most… https://t.co/NxK1HkjyPn #Pub